CYM5442

CAS No. 1094042-01-9

CYM5442( CYM-5442 | CYM 5442 | CYM5442 )

Catalog No. M10363 CAS No. 1094042-01-9

CYM5442 is a S1P agonist, target to Sphingosine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 141 In Stock
25MG 267 In Stock
50MG 503 In Stock
100MG 710 In Stock
500MG 1494 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CYM5442
  • Note
    Research use only, not for human use.
  • Brief Description
    CYM5442 is a S1P agonist, target to Sphingosine.
  • Description
    CYM5442 is a S1P agonist, target to Sphingosine.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Adult male albino Wistar rats (8-10 weeks old; 180-230 g) infected ocular endothelin-1 (ET-1) Dosage:1 mg/kg Administration:Intraperitoneal injection; daily; for 5 days Result:Visual evoked potentials (VEP) showed preserved visual function. Showed significantly higher retinal ganglion cells (RGCs) numbers.
  • Synonyms
    CYM-5442 | CYM 5442 | CYM5442
  • Pathway
    GPCR/G Protein
  • Target
    S1P Receptor
  • Recptor
    SphK
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1094042-01-9
  • Formula Weight
    409.49
  • Molecular Formula
    C23H27N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: > 10 mM
  • SMILES
    CCOC1=CC=C(C2=NC(C3=CC=CC4=C3CCC4NCCO)=NO2)C=C1OCC
  • Chemical Name
    2-((4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)amino)ethan-1-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Poti F, et al. Vascul Pharmacol. 2012 Aug 19;57(1):56-64.
molnova catalog
related products
  • GSK2018682

    GSK2018682 is an agonist of sphingosine-1-phosphate receptor ?(s1p1) and (s1p5) agonist(pEC50s of 7.7 and 7.2respectively).

  • XL413

    XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.

  • WAY-272077

    WAY-272077 is a sphingosine kinase inhibitor with anti-inflammatory, antitumor and hemostatic effects.